While validating the suppressive activity of ERβ in AR-positive prostate cancer cells, these findings also indicate that downregulation of MYC also mediates ERβ’s tumor suppressor activity in AR-positive prostate cancer cells. Here, ESR2 is linked to prostate cancer.